Dietary supplement formulations for promoting sleep
Provided herein are formulations and methods helping individuals enhance cognitive function, facilitate memory processing, induce and maintain sleep, stabilize mood, reduce symptoms of stress and anxiety, facilitate energy production, improve mental and emotional health, or support long-term brain health.
1. A sleep supplement formulation comprising:
a. L-glutamine or a salt thereof, wherein the L-glutamine is present in an amount from about 1 mg to about 50 mg,
b. L-theanine or a salt thereof, wherein the L-theanine is present in an amount from about 10 mg to about 300 mg,
c. taurine or a salt thereof, wherein the taurine is present in an amount from about 10 mg to about 120 mg,
d. GABA, wherein the GABA is present in an amount from about 10 mg to about 600 mg,
e. melatonin, wherein the melatonin is present in an amount from about 1 mg to about 20 mg,
f. phosphatidylserine, wherein the phosphatidylserine is present in an amount from about 0.1 mg to about 4 mg,
g. myo-inositol, wherein said myo-inositol is present in said formulation in an amount of from about 8 mg to about 40 mg; and
h. one or more physiologically or pharmaceutically acceptable carrier, wherein components (a)-(g) are formulated with the carrier in the form of a solid dosage for promoting sleep.
2. The sleep supplement formulation of claim 1 , wherein said myo-inositol is present in said formulation in an amount of about 16 mg.
3. The sleep supplement formulation of claim 1 , wherein said L-glutamine or a salt thereof is present in said formulation in an amount of from about 8 mg to about 50 mg.
4. The sleep supplement formulation of claim 1 , wherein said L-theanine is present in said formulation in an amount of about 140 mg.
5. The sleep supplement formulation of claim 1 , wherein said taurine or a salt thereof is present in said formulation in an amount of about 64 mg.
6. The sleep supplement formulation of claim 1 , wherein said GABA is present in said formulation in an amount of about 300 mg.
7. The sleep supplement formulation of claim 1 , wherein said melatonin or a salt thereof is present in said formulation in an amount of from about 7 mg to about 20 mg.
8. The sleep supplement formulation of claim 1 , wherein said phosphatidylserine or a salt thereof is present in said formulation in an amount of from about 0.5 mg to about 4 mg.
9. The sleep supplement formulation of claim 1 , further comprising:
a. valerian root extract, wherein the valerian root extract is present in an amount from about 50 mg to about 300 mg;
b. chamomile flower extract, wherein the chamomile flower extract is present in an amount from about 10 mg to about 50 mg;
c. hops flower extract, wherein the hops flower extract is present in an amount from about 10 mg to about 50 mg;
d. passion flower extract, wherein the passion flower extract is present in an amount from about 8 mg to about 60 mg;
e. lemon balm leaf extract, wherein the lemon balm leaf extract is present in an amount from 1 mg to about 60 mg;
f. 5 hydroxytryptophan or a salt thereof, wherein the 5-hydroxytryptophan is present in an amount from about 8 mg to about 60 mg; and
g. ashwagandha root extract, wherein the ashwagandha root extract is present in said formulation in an amount of from about 8 mg to about 60 mg.
10. The sleep supplement formulation of claim 9 , wherein said ashwagandha root extract is present in said formulation in an amount of about 28 mg.
11. The sleep supplement formulation of claim 9 , wherein said valerian root extract is present in said formulation in an amount of about 140 mg.
12. The sleep supplement formulation of claim 9 , wherein said chamomile flower extract is present in said formulation in an amount of about 24 mg.
13. The sleep supplement formulation of claim 9 , wherein said hops flower extract is present in said formulation in an amount of about 24 mg.
14. The sleep supplement formulation of claim 9 , wherein said 5-hydroxytryptophan or a salt thereof is present in said formulation in an amount of about 34 mg.
15. The sleep supplement formulation of claim 9 , wherein said passion flower extract is present in said formulation in an amount of about 20 mg.
16. The sleep supplement formulation of claim 9 , wherein said lemon balm leaf extract is present in said formulation in an amount of from about 8 mg to about 60 mg.
17. A method of promoting sleep in an individual in need thereof, by orally administering to the individual a supplement formulation comprising:
a. L-glutamine or a salt thereof, wherein the L-glutamine is present in an amount from about 8 mg to about 50 mg,
b. L-theanine or a salt thereof, wherein the L-theanine is present in an amount from about 10 mg to about 300 mg,
c. taurine or a salt thereof, wherein the taurine is present in an amount from about 10 mg to about 120 mg,
d. GABA wherein the GABA is present in an amount from about 10 mg to about 600 mg,
e. melatonin, wherein the melatonin is present in an amount from about 1 mg to about 20 mg,
f. phosphatidylserine, wherein the phosphatidylserine is present in an amount from about 0.1 mg to about 4 mg,
g. myo-inositol, wherein said myo-inositol is present in said formulation in an amount of from about 8 mg to about 40 mg; and
one or more physiologically or pharmaceutically acceptable carrier, wherein components (a)-(g) are formulated with the carrier in the form of a solid dosage for promoting sleep.